Loading...
Publication
Cancro da Mama: farmacoterapia e Intervenção do Farmacêutico
| Name: | Description: | Size: | Format: | |
|---|---|---|---|---|
| 1.92 MB | Adobe PDF |
Authors
Advisor(s)
Abstract(s)
O cancro é uma das principais causas de morte em todo o mundo, sendo o carcinoma da mama, de origem heterogénea e multifatorial, a neoplasia com maior incidência entre as mulheres. Apesar da evolução científica e do desenvolvimento de novas estratégias terapêuticas, o cancro da mama ainda continua a ser associado a elevada prevalência e mortalidade. O cancro da mama pode ser distinguido em três tipos principais, isto é, recetor hormonal positivo/HER2 negativo, HER2 positivo e triplo negativo, que influenciam a resposta às terapêuticas e os resultados clínicos.
Cancer is one of the main causes of death worldwide, with breast carcinoma, of heterogeneous and multifactorial origin, being the neoplasm with the highest incidence among women. Despite scientific evolution and the development of new therapeutic strategies, breast cancer still continues to be associated with high prevalence and mortality. Breast cancer can be distinguished into three main types, that is, hormone receptor positive/HER2 negative, HER2 positive and triple negative, which influence the response to therapies and clinical results.
Cancer is one of the main causes of death worldwide, with breast carcinoma, of heterogeneous and multifactorial origin, being the neoplasm with the highest incidence among women. Despite scientific evolution and the development of new therapeutic strategies, breast cancer still continues to be associated with high prevalence and mortality. Breast cancer can be distinguished into three main types, that is, hormone receptor positive/HER2 negative, HER2 positive and triple negative, which influence the response to therapies and clinical results.
Description
Keywords
Cancro da mama Farmacoterapia Incidência Rastreio Farmacêutico